Thankfully we know that the facility has been inspected - read the link below - would have hated ACL to be on that list - so i guess its now only a matter of FDA sorting its backlog rather than anything else (anything negative i.e.)
Link:
http://www.fdanews.com/newsletter/article?articleId=134448&issueId=14487
On the positive side - it keeps giving opportunities to accumalate more as and when resources / portfolio permit.
Currently my portfolio is heavy on 2 biotechs - and strangely enough (or maybe its a sign) both are expected to announce company changing and SP multiplication deals / announcements.
No advice given or intended - DYOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable